-
1.发明申请Pharmaceutical compositions for the treatment of hyper-proliferative disorders 审中-公开用于治疗高增殖性疾病的药物组合物公开(公告)号：US20060058358A1
公开(公告)日：2006-03-16
申请号：US11212109
申请日：2005-08-26
申请人： Jacques Dumas , Paul Ehrlich , Susanne Zuleger
发明人： Jacques Dumas , Paul Ehrlich , Susanne Zuleger
IPC分类号： A61K31/4415
CPC分类号： A61K31/44 , A61K9/0053 , A61K9/146 , A61K9/1623 , A61K9/1635 , A61K9/1652 , A61K9/2027 , A61K9/2054 , A61K9/48 , A61K31/4415
摘要： This invention relates to novel pharmaceutical compositions comprising a solid dispersion of the compound of Formula I below, to processes for preparing these novel pharmaceutical compositions and to their use for treating hyper-proliferative disorders, such as cancer, either as a sole agent or in combination with other therapies. Formula I is as follows:
摘要翻译： 本发明涉及包含以下式I化合物的固体分散体的新型药物组合物，用于制备这些新型药物组合物的方法及其用于治疗高增殖性疾病如癌症的用途，作为唯一的药剂或组合 与其他疗法。 公式I如下：
-
公开(公告)号：US20060154912A1
公开(公告)日：2006-07-13
申请号：US10537623
申请日：2003-11-28
申请人： Michael Harter , Jens Erguden , Frank Wunder , Hanna Tinel , Johannes Kobberling , Eva-Maria Becker , Klaus Munter , Karl-Heinz Schlemmer , Raimund Kast , Peter Kolkhof , Gunter Karig , Lars Barfacker , Walter Hubsch , Joachim Schuhmacher , Susanne Zuleger , Arnel Concepcion , Haruka Shimizu
发明人： Michael Harter , Jens Erguden , Frank Wunder , Hanna Tinel , Johannes Kobberling , Eva-Maria Becker , Klaus Munter , Karl-Heinz Schlemmer , Raimund Kast , Peter Kolkhof , Gunter Karig , Lars Barfacker , Walter Hubsch , Joachim Schuhmacher , Susanne Zuleger , Arnel Concepcion , Haruka Shimizu
IPC分类号： A61K31/455 , A61K31/397 , A61K31/195 , A61K31/445
CPC分类号： C07D319/08 , C07C235/60 , C07C235/62 , C07C2601/02 , C07C2601/08 , C07C2601/14 , C07C2602/10 , C07D205/04 , C07D211/34 , C07D211/60 , C07D211/62 , C07D307/58 , C07D317/54 , C07D317/62 , C07D319/06 , C07D405/12
摘要： The present invention relates to isophthalic acid derivatives, to a process for their preparation and to their use for producing medicaments for the treatment and/or prophylaxis of diseases in humans and animals, in particular of cardiovascular disorders.
摘要翻译： 本发明涉及间苯二甲酸衍生物，其制备方法及其用于制备用于治疗和/或预防人和动物特别是心血管疾病疾病的药物。
-
公开(公告)号：US07498460B2
公开(公告)日：2009-03-03
申请号：US10537623
申请日：2003-11-28
申请人： Michael Härter , Jens Ergüden , Frank Wunder , Hanna Tinel , Johannes Köbberling , Eva-Maria Becker , Klaus Münter , Karl-Heinz Schlemmer , Raimund Kast , Peter Kolkhof , Gunter Karig , Lars Bärfacker , Walter Hübsch , Joachim Schuhmacher , Susanne Zuleger , Arnel Concepcion , Haruka Shimizu
发明人： Michael Härter , Jens Ergüden , Frank Wunder , Hanna Tinel , Johannes Köbberling , Eva-Maria Becker , Klaus Münter , Karl-Heinz Schlemmer , Raimund Kast , Peter Kolkhof , Gunter Karig , Lars Bärfacker , Walter Hübsch , Joachim Schuhmacher , Susanne Zuleger , Arnel Concepcion , Haruka Shimizu
IPC分类号： C07C229/10
CPC分类号： C07D319/08 , C07C235/60 , C07C235/62 , C07C2601/02 , C07C2601/08 , C07C2601/14 , C07C2602/10 , C07D205/04 , C07D211/34 , C07D211/60 , C07D211/62 , C07D307/58 , C07D317/54 , C07D317/62 , C07D319/06 , C07D405/12
摘要： The present invention relates to isophthalic acid derivatives, to a process for their preparation and to their use for producing medicaments for the treatment and/or prophylaxis of diseases in humans and animals, in particular of cardiovascular disorders.
摘要翻译： 本发明涉及间苯二甲酸衍生物，其制备方法及其用于制备用于治疗和/或预防人和动物特别是心血管疾病疾病的药物。
-
公开(公告)号：US20080268046A1
公开(公告)日：2008-10-30
申请号：US11579904
申请日：2005-04-29
申请人： Susanne Zuleger , Peter Serno , Helmut Haning , Kerstin Pauli , Roland Heinig
发明人： Susanne Zuleger , Peter Serno , Helmut Haning , Kerstin Pauli , Roland Heinig
CPC分类号： A61K31/53 , A61K9/0004 , A61K9/2054 , A61K9/209 , A61K9/5042 , A61K9/5047 , A61K9/5078 , A61K31/522 , A61K45/06 , A61K2300/00
摘要： The present invention relates to novel pharmaceutical dosage forms with controlled release of active ingredient which comprise the PDE 5 inhibitor vardenafil and/or pharmaceutically acceptable salts, hydrates, solvates and/or polymorphic forms thereof as active ingredient, and to the production thereof. The invention further relates to the use of these novel pharmaceutical dosage forms as medicaments, and to their use for producing medicaments for the treatment and/or prevention of disorders in humans and animals.
摘要翻译： 本发明涉及含有PDE5抑制剂伐地那非和/或其药学上可接受的盐，水合物，溶剂合物和/或其多晶型物作为活性成分的活性成分的控制释放的新药物剂型及其制备方法。 本发明还涉及这些新型药物剂型作为药物的用途，以及其用于制备用于治疗和/或预防人和动物疾病的药物的用途。
-
公开(公告)号：US20080187588A1
公开(公告)日：2008-08-07
申请号：US11579925
申请日：2005-05-10
申请人： Susanne Zuleger , Peter Serno , Helmut Haning , Kerstin Pauli , Roland Heinig
发明人： Susanne Zuleger , Peter Serno , Helmut Haning , Kerstin Pauli , Roland Heinig
IPC分类号： A61K9/26 , A61K31/4985 , A61P15/10 , A61K9/00
CPC分类号： A61K31/53 , A61K9/0004 , A61K9/2054 , A61K9/209 , A61K9/5042 , A61K9/5047 , A61K9/5078 , A61K31/522 , A61K45/06 , A61K2300/00
摘要： The present invention relates to novel pharmaceutical dosage forms with controlled release of active ingredient which comprise the PDE 5 inhibitor vardenafil and/or pharmaceutically acceptable salts, hydrates, solvates and/or polymorphic forms thereof as active ingredient, and to the production thereof. The invention further relates to the use of these novel pharmaceutical dosage forms as medicaments, and to their use for producing medicaments for the treatment and/or prevention of disorders in humans and animals.
摘要翻译： 本发明涉及含有PDE5抑制剂伐地那非和/或其药学上可接受的盐，水合物，溶剂合物和/或其多晶型物作为活性成分的活性成分的控制释放的新药物剂型及其制备方法。 本发明还涉及这些新型药物剂型作为药物的用途，以及其用于制备用于治疗和/或预防人和动物疾病的药物的用途。
-
-
-
-
搜索结果
5 条记录 (耗时 0.023 秒)
